# Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression

> **NCT01794455** · PHASE4 · TERMINATED · sponsor: **Vanderbilt University** · enrollment: 1 (actual)

## Conditions studied

- Depression
- Hypertension

## Interventions

- **DRUG:** Sertraline
- **DRUG:** Candesartan

## Key facts

- **NCT ID:** NCT01794455
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Enrollment difficulties
- **Last updated:** 2016-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794455, "Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01794455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*